Nomura Asset Management Co. Ltd. Has $4.75 Million Stake in AmerisourceBergen Corp. (NYSE:ABC)

Nomura Asset Management Co. Ltd. decreased its stake in AmerisourceBergen Corp. (NYSE:ABC) by 44.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 55,650 shares of the company’s stock after selling 44,020 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in AmerisourceBergen were worth $4,745,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its position in AmerisourceBergen by 8.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 960,038 shares of the company’s stock valued at $71,426,000 after buying an additional 73,642 shares during the last quarter. Geode Capital Management LLC raised its position in AmerisourceBergen by 6.2% in the 4th quarter. Geode Capital Management LLC now owns 1,954,861 shares of the company’s stock valued at $145,173,000 after buying an additional 114,505 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its position in AmerisourceBergen by 238.8% in the 1st quarter. Robeco Institutional Asset Management B.V. now owns 10,240 shares of the company’s stock valued at $813,000 after buying an additional 7,218 shares during the last quarter. First Allied Advisory Services Inc. raised its position in AmerisourceBergen by 3.0% in the 1st quarter. First Allied Advisory Services Inc. now owns 10,276 shares of the company’s stock valued at $813,000 after buying an additional 297 shares during the last quarter. Finally, Cetera Advisor Networks LLC raised its position in AmerisourceBergen by 3.1% in the 1st quarter. Cetera Advisor Networks LLC now owns 6,878 shares of the company’s stock valued at $550,000 after buying an additional 205 shares during the last quarter. 65.95% of the stock is currently owned by hedge funds and other institutional investors.

ABC stock traded down $0.22 during mid-day trading on Tuesday, reaching $83.57. The company had a trading volume of 309,042 shares, compared to its average volume of 1,164,206. The company has a debt-to-equity ratio of 1.40, a current ratio of 0.95 and a quick ratio of 0.56. The stock has a 50 day simple moving average of $86.00 and a two-hundred day simple moving average of $81.97. The company has a market capitalization of $17.53 billion, a price-to-earnings ratio of 12.88, a PEG ratio of 1.49 and a beta of 1.00. AmerisourceBergen Corp. has a 52 week low of $69.36 and a 52 week high of $94.85.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.76 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.62 by $0.14. The firm had revenue of $45.24 billion during the quarter, compared to the consensus estimate of $45.15 billion. AmerisourceBergen had a return on equity of 47.88% and a net margin of 0.54%. The business’s revenue was up 4.9% compared to the same quarter last year. During the same period last year, the company earned $1.54 earnings per share. On average, equities analysts predict that AmerisourceBergen Corp. will post 7.05 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 3rd. Shareholders of record on Monday, August 19th were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.91%. AmerisourceBergen’s dividend payout ratio is 24.65%.

In other news, CEO Steven H. Collis sold 19,905 shares of AmerisourceBergen stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $86.89, for a total transaction of $1,729,545.45. Following the completion of the transaction, the chief executive officer now directly owns 154,484 shares in the company, valued at approximately $13,423,114.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John G. Chou sold 13,997 shares of AmerisourceBergen stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $89.58, for a total value of $1,253,851.26. Following the transaction, the insider now owns 65,782 shares of the company’s stock, valued at $5,892,751.56. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 186,215 shares of company stock valued at $16,240,235. Corporate insiders own 27.80% of the company’s stock.

A number of equities research analysts recently issued reports on the company. Deutsche Bank assumed coverage on AmerisourceBergen in a research report on Thursday, September 12th. They issued a “hold” rating and a $91.00 target price on the stock. Morgan Stanley dropped their target price on AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, September 6th. Argus dropped their target price on AmerisourceBergen from $115.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, June 3rd. Zacks Investment Research raised AmerisourceBergen from a “hold” rating to a “buy” rating and set a $89.00 target price on the stock in a research report on Wednesday, June 12th. Finally, ValuEngine lowered AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Tuesday, August 6th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $87.38.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Featured Article: Asset Allocation and Your Retirement

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.